Dementia Researcher

In this podcast we welcome academics and industry to discuss the Dementia Consortium and drug discovery, from the basics of target validation to the question you always wanted to ask big pharma - what is their motivation for investing! The panel is made up of Dr Declan Jones and Dr John Isaac both from Johnson & Johnson, one of the seven industry partners of the Dementia Consortium, Professor Paul Whiting, the CSO at the Drug Discovery Institute at UCL and James Connell the Research Manager at Alzheimer's Research UK who coordinates the Dementia Consortium. The Dementia Consortium is a private-charity partnership between Alzheimer’s Research UK, Evotec and the pharmaceutical companies Abbvie, Astex Pharmaceuticals, Eisai, Johnson & Johnson, Lilly and MSD. The Consortium provides drug discovery resources, project management, industry expertise and tools as well as full funding support for projects. It can support small molecule or antibody-based strategies and aims to generate tools to achieve preclinical t